Experts from BRG recently discussed the two presidential candidates' stances on key healthcare issues, including drug pricing ...

The fee-for-service (FFS) payment model that has been the norm in healthcare for decades may finally be on its way out, with many physicians and hospital leaders leaning into value-based care (VBC).

Last year, researchers looked at the directories of the nation’s five largest health plans and found that four out of five entries were inaccurate. This is more than a minor inconvenience.

HLTH 2024, scheduled for October 20-23 at the Venetian Expo Center in Las Vegas, will highlight new programming, a physicians roundtable, generative AI, the shifting landscapes of telemedicine ...

Suki, a company offering AI voice solutions to healthcare companies, has secured $70 million in Series D funding, it announced Thursday. The financing will help the company build new products.

Neuroscience drug developer Lundbeck is expanding its scope to epilepsy via the $2.6 billion acquisition of Longboard Pharmaceuticals, a company whose lead asset is in late-stage clinical ...

Rural Americans have long experienced poorer health outcomes compared to their urban counterparts. New evidence shows that the divide is widening, with rural adults aged 25 to 54 significantly ...

Depression, a common yet complex mental health issue, affects millions worldwide. Despite its prevalence and long clinical history, treating depression remains fraught with challenges. A diagnosis ...

Ashley Tyrner has gone from being a single mom on food stamps where she experienced firsthand life as an economically disadvantaged minority to the founder and CEO of FarmboxRx – a leading food ...

Arundhati Parmar is VP and Editor-in-Chief at MedCity News. In this role, she oversees MedCity's news coverage as well as develops the content for several conferences that the publication hosts.

The conundrum of American health care has become all too familiar: While spending outpaces other high-income countries, our quality of care often lags our peers – demonstrating no real ...

Asthma patients have many drug options, but many patients find these choices either inconvenient or inadequate for severe cases of the chronic respiratory condition. Upstream Bio is pursuing a ...